WIC + RDN Referrals for Maternal Health
(FIMPreg Trial)
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on WIC referrals and dietitian consultations, so it's unlikely that medication changes are required.
What data supports the effectiveness of the treatment RDN Referral, WIC Referral for maternal health?
How does the WIC + RDN Referrals treatment differ from other treatments for maternal health?
The WIC + RDN Referrals treatment is unique because it combines nutrition education and supplemental food with referrals to health and welfare services, addressing both nutritional and broader health needs of low-income pregnant and postpartum women. This approach not only provides immediate nutritional support but also connects participants to additional resources like medical, dental, and social services, which is not typically part of standard maternal health treatments.26789
What is the purpose of this trial?
This study is being done to find out if online referrals to a food management program for Women, Infants, and Children (WIC) made by clinical teams will get more people to enroll in WIC. Women aged 18 or older who get healthcare at Geisinger, are pregnant, and are eligible to be referred to the WIC program will be recruited. These women need to consent to join this study. There are four groups in this study. Group 1 will get usual care with details about WIC from their clinical team. Group 2 will be sent to WIC by their clinical team. The study team may help the clinical team with the referrals. Group 3 will get details about WIC from their clinical team and a dietitian will talk to them about heart-healthy diets and food management. Group 4 will be sent to WIC by their clinical team or study team and a dietitian will talk to them about heart-healthy diets and food management. Participants who talk with the dietitians will be sent kitchen utensils based on need. This study will last about 18 months and will have 240 total subjects joining at about 60 per month. Each subject will be in the study for about 6 months. Subjects will be asked to complete surveys at the start and end of the study. Some subjects will also be asked about their experience in the study after they are done.
Research Team
Lisa Bailey-Davis, DEd
Principal Investigator
Geisinger Clinic
Eligibility Criteria
This trial is for English-speaking pregnant women with public insurance or no insurance, planning to deliver at a Geisinger facility in one of seven targeted counties. They must be willing to consent and participate for up to 12 months. Women already enrolled in WIC as pregnant persons or those with private insurance cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Enrollment and Intervention
Participants are enrolled and assigned to one of four groups to receive WIC information and/or referrals, with some receiving additional dietitian consultations
Follow-up
Participants are monitored for WIC enrollment, RDN visit adherence, and prenatal clinic visit adherence
Treatment Details
Interventions
- RDN Referral
- WIC Referral
Find a Clinic Near You
Who Is Running the Clinical Trial?
Geisinger Clinic
Lead Sponsor
American Heart Association
Collaborator
Family Health Council of Central Pennsylvania (FHCCP)
Collaborator